ப்ரெஸிடெஂட் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Serie A, convocata d urgenza un assemblea per mercoledì 21 luglio
milannews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from milannews.it Daily Mail and Mail on Sunday newspapers.
Student leaders express concern on proposal for exceptional tuition increase
thegauntlet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thegauntlet.ca Daily Mail and Mail on Sunday newspapers.
BioArctic receives patent in Japan for new antibodies targeting Alzheimer s disease
News provided by
Share this article
Share this article
STOCKHOLM, May 11, 2021 /PRNewswire/ BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the Japanese Patent Office (JPO) has allowed the company s Japanese patent application 2017-083057 for novel antibodies that could be developed into a treatment for Alzheimer s disease. The antibodies target a shorter (truncated) form of amyloid beta (pE3-Aβ) and are linked to the company s project AD1503. BioArctic received a patent in Europe based on the same antibodies in January 2021.
The allowed patent application focuses on novel antibodies which target pE3-Aβ, a specific truncated form of amyloid beta. Monomers of pE3-Aβ are highly prone to aggregate, leading to the formation of harmful soluble Aβ aggregates (protofibrils) which could cause debilitating cognitive and other symptoms in Alzheimer s disease.
Aggiuntivo all ordine del giorno del Consiglio Comunale del 17 05 2021
emiliaromagnanews24.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from emiliaromagnanews24.it Daily Mail and Mail on Sunday newspapers.
TechnipFMC plc: TechnipFMC Announces First Quarter 2021 Results
Cash flow from continuing operations $182 million, free cash flow $137 million
Subsea inbound orders more than doubled sequentially to $1.5 billion
New partnerships leverage subsea expertise for integrated wind, wave energy
Regulatory News:
Summary Financial Results from Continuing Operations
Reconciliation of U.S. GAAP to non-GAAP financial measures are provided in financial schedules.
Three Months Ended
March 31,
$0.95
$(0.03)
(11.9%)
Total Company revenue in the first quarter was $1,632 million. Income from continuing operations attributable to TechnipFMC plc was $430.3 million, or $0.95 per diluted share. These results included income from the Company s equity investment in Technip Energies of $470.1 million primarily related to a favorable change in fair market value. After-tax charges and credits totaled $444.8 million of credit, or $0.99 per diluted share. Adjusted loss from continuing operations